Publications by authors named "B Carpentier"

Claim this Profile
M
MMS22L is a novel key actor of normal and pathological erythropoiesis.
Elia Colin, Ivan Ferrer-Vicens, Dror Brook, Mohammad Salma, Charlotte Andrieu-Soler, Benjamin Carpentier

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.
Leïla Ben Dhia, Mathieu Wemeau, Laurène Fenwarth, Alice Marceau-Renaut, Elise Fournier, Benjamin Carpentier

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).
Armand Mekontso Dessap, Anoosha Habibi, Constance Guillaud, Christian Kassasseya, Charlotte Larrat, Benjamin Carpentier

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.
Laurène Fenwarth, Benjamin Podvin, Loïc Vasseur, Delphine Lebon, Guillaume Couillez, Benjamin Carpentier

Eur J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.
Christophe Willekens, Alexandre Bazinet, Samy Chraibi, Alex Bataller, Justine Decroocq, Benjamin Carpentier

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis